| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Thomas Woiwode | Director | $5M | Jun 17, 2022 | ||
| Versant Vantage II, L.P. | 10%+ Owner | $5M | Apr 29, 2022 | ||
| Versant Venture Capital VI, L.P. | 10%+ Owner | $2.56M | Aug 8, 2024 | ||
| Stella Xu | Director | $1.37M | Jul 1, 2021 | ||
| Thomas W. Dubensky | President, Director | $267K | Jan 3, 2023 | ||
| Rock Springs Capital Management LP | 10%+ Owner | $174K | Dec 30, 2021 | ||
| Stephen R. Brady | President and CEO, Director | $97.9K | Jan 2, 2025 | ||
| Justin Trojanowski | Corporate Controller | $47.9K | Jan 2, 2025 | ||
| Samuel Whiting | Chief Medical Officer | $20.4K | Jan 2, 2025 | ||
| Pierre Lorenzo | Corporate Controller | $125 | Jun 21, 2022 | ||
| Michael Raab | Director | Jun 13, 2024 | |||
| Christine Pellizzari | Director | Jun 13, 2024 | |||
| Ronit Simantov | Director | Jun 13, 2024 | |||
| Geoffrey Nichol | Director | Jun 13, 2024 | |||
| Nicholas Maestas | Chief Financial Officer | Jan 2, 2025 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|